back to blog roll

Here is what we know and what we don't know about HBOT and COVID-19

  • Synopsis: UHMS Hyperbaric Oxygen Therapy Committee Meeting on COVID-19 and HBO2. This is a synopsis of a conference call between invited members of the Hyperbaric Oxygen Therapy committee, the American College of Emergency Physicians’ Section on Undersea and Hyperbaric Medicine, and invited researchers with clinical trials on the use of HBO2 and COVID- 19. This is a synopsis of the discussion curated from a recording of the meeting.
  • UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients - Date created: April 8, 2020 - There have been numerous recent inquiries regarding use of hyperbaric oxygen (HBO2) for patients with COVID-19. Questions have been raised pertinent to two possible mechanisms for HBO2 in this clinical context:  support of oxygenation and attenuation of pulmonary inflammation.  Based on a review of the current literature, discussion with hyperbaric researchers working on this topic, and senior UHMS members, the following conclusions and recommendations are provided.
Explore our Wound Care and Hyperbaric Solutions